Atrion (NASDAQ:ATRI) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Atrion (NASDAQ:ATRI) in a report published on Wednesday. The brokerage issued a sell rating on the medical instruments supplier’s stock.

Atrion Stock Up 0.1 %

NASDAQ:ATRI opened at $459.92 on Wednesday. Atrion has a twelve month low of $274.98 and a twelve month high of $503.24. The stock’s 50-day simple moving average is $458.42 and its 200 day simple moving average is $442.63. The firm has a market capitalization of $809.46 million, a PE ratio of 43.23 and a beta of 0.69.

Atrion (NASDAQ:ATRI) last posted its quarterly earnings results on Thursday, August 8th. The medical instruments supplier reported $0.23 earnings per share for the quarter. The company had revenue of $48.77 million for the quarter. Atrion had a net margin of 10.60% and a return on equity of 7.75%.

Institutional Investors Weigh In On Atrion

Hedge funds have recently modified their holdings of the company. Quadrant Capital Group LLC bought a new position in Atrion in the fourth quarter valued at about $36,000. Headlands Technologies LLC acquired a new stake in Atrion in the second quarter valued at $54,000. Benjamin F. Edwards & Company Inc. acquired a new stake in Atrion in the second quarter valued at $72,000. EntryPoint Capital LLC bought a new position in Atrion during the 1st quarter worth $91,000. Finally, Comerica Bank grew its position in shares of Atrion by 60.9% in the 1st quarter. Comerica Bank now owns 415 shares of the medical instruments supplier’s stock valued at $192,000 after buying an additional 157 shares during the last quarter. Institutional investors and hedge funds own 66.19% of the company’s stock.

About Atrion

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.